Six Industry Experts Join National Psoriasis Foundation Medical Board
Portland, Ore. (August 13, 2018)—The National Psoriasis Foundation, NPF, has appointed six experts highly regarded for their work in the psoriatic disease community to its medical board. With a focus in both clinical and scientific research, the addition of these leaders complements the expertise and perspective in both psoriasis and psoriatic arthritis of the 25 other board members. New board members include:
Steven Feldman, M.D., Ph.D. Dr. Feldman is professor of dermatology, at Wake Forest University School of Medicine. Dr. Feldman, who previously served on the NPF medical board from 1999-2005, leads the Center for Dermatology Research, a health services research center whose mission is to improve the care of patients with skin disease.
Dafna Gladman, M.D., FRCPC. Dr. Gladman is professor of medicine at the University of Toronto. Receiving her M.D., from the University of Toronto in 1971, Gladman completed her post‐graduate training in rheumatology at the University of Toronto and undertook training in tissue typing with Paul Terasaki at ULCA. She started an HLA laboratory at the Wellesley Hospital in 1979, was a staff rheumatologist at Women’s College Hospital in Toronto from 1978 to 1990 and at the Wellesley Hospital from 1990 to 1995. Dr. Gladman is returning to the NPF medical board having previously served from 2003-2009.
Leon Kircik, M.D. A board-certified dermatologist, Dr. Kircik is an associate clinical professor of dermatology at Mount Sinai Medical Center and Indiana University Medical Center. Kircik graduated from State University of New York at the Health Sciences Center at Brooklyn and completed his undergraduate work at New York University.
Wilson Liao, M.D. Dr. Liao serves as director of the Psoriasis and Skin Treatment Center at University of California San Francisco. The Liao laboratory studies the genetics and environmental triggers of psoriasis, a common immune-mediated skin disease. Liao directs the UCSF Psoriasis Research Initiative and Biobank with over 1,000 subjects, which is used for genetic and translational research studies.
Ana Maria Orbai, M.D., MHS. Dr. Orbai is an assistant professor of medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. Actively involved in patient care at the Johns Hopkins Arthritis Center, Orbai’s predominant focus is psoriatic arthritis and rheumatoid arthritis.
Jeffrey Weinberg, M.D. Weinberg is an associate clinical professor of dermatology, at Mount Sinai School of Medicine. Dr. Weinberg graduated from the University Of Pennsylvania School Of Medicine in Philadelphia and completed an internship in medicine at Columbia-Presbyterian Medical Center in New York City and a residency in dermatology at the University Of Pennsylvania School Of Medicine. This is Weinberg’s second term on the NPF Medical Board, he previously served from 2011-2017.
While these six experts join the medical board, two will be transitioning off the board. NPF would like to recognize and thank April Armstrong, MD, MPH and Ronald Prussick, MD, FRCP for their dedication and service to the NPF.
The NPF medical board provides guidance and leadership to the organization on all medical issues related to the psoriatic disease patient community. The board also facilitates access to quality care by advocating for better clinical research tools, promoting medical education, and identifying and promoting medical professionals who most effectively treat psoriatic disease. To learn more about the NPF medical board visit www.psoriasis.org/medical-board.
About the National Psoriasis Foundation
Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $21 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at www.psoriasis.org.